Advertisement
Advertisement
ATRC
AtriCure, Inc.
29.98
USDSponsored
+0.45
+1.53%
Mar 26, 15:59 UTC -4
Closed
After-Market
30.00
+0.01
+0.05%
ATRC Earnings Reports
Positive Surprise Ratio
ATRC beat 31 of 41 last estimates.
76%
Next Report
Date of Next Report
Apr 27, 2026
Estimate for Q1 26 (Revenue/ EPS)
$142.35M
/-$0.07
Implied change from Q4 25 (Revenue/ EPS)
+1.32%
/-275.00%
Implied change from Q1 25 (Revenue/ EPS)
+15.15%
/-50.00%
AtriCure, Inc. earnings per share and revenue
On Feb 17, 2026, ATRC reported earnings of 0.04 USD per share (EPS) for Q4 25, beating the estimate of -0.09 USD, resulting in a 141.28% surprise. Revenue reached 140.50 million, compared to an expected 142.57 million, with a -1.45% difference. The market reacted with a -3.29% price change (close before vs. close after earnings).
Looking ahead to Q1 26, 11 analysts forecast an EPS of -0.07 USD, with revenue projected to reach 142.35 million USD, implying an decrease of -275.00% EPS, and increase of 1.32% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Capricor Therapeutics Inc
Report Date
Mar 12, 2026 For Q4 25
Estimate
-$0.55
Actual
-$0.62
Surprise
-12.56%
Kestra Medical Technologies, Ltd. Common Stock
Report Date
Mar 17, 2026 For Q3 26
Estimate
-$0.60
Actual
-$0.61
Surprise
-0.39%
Sundial Growers Inc. Common Shares
Report Date
Mar 12, 2026 For Q4 25
Estimate
-$0.01
Actual
$0.04
Surprise
+499.62%
High Tide Inc. Common Shares
Report Date
Mar 17, 2026 For Q1 26
Estimate
$0.00
Actual
$0.01
Surprise
+447.68%
Sanara MedTech Inc. Common Stock
Report Date
Mar 24, 2026 For Q4 25
Estimate
$0.11
Actual
$0.04
Surprise
-64.35%
Cytosorbents Corp.
Report Date
Mar 25, 2026 For Q4 25
Estimate
-$0.05
Actual
-$0.09
Surprise
-76.47%
Nephros Inc.
Report Date
Mar 12, 2026 For Q4 25
Estimate
$0.01
Actual
$0.08
Surprise
+684.31%
FAQ
What were AtriCure, Inc.'s earnings and revenue for the latest quarter Q4 2025?
For Q4 2025, AtriCure, Inc. reported EPS of $0.04, beating estimates by 141.28%, and revenue of $140.50M, -1.45% below expectations.
How did the market react to AtriCure, Inc.'s Q4 2025 earnings?
The stock price moved down -3.29%, changed from $37.64 before the earnings release to $36.40 the day after.
When is AtriCure, Inc. expected to report next?
The next earning report is scheduled for Apr 27, 2026.
What are the forecasts for AtriCure, Inc.'s next earnings report?
Based on 11
analysts, AtriCure, Inc. is expected to report EPS of -$0.07 and revenue of $142.35M for Q1 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement